Understanding Lung Cell Responses to Tuberculosis
Ontogeny and metabolism of lung alveolar macrophages in tuberculosis
['FUNDING_R01'] · UNIV OF ARKANSAS FOR MED SCIS · NIH-11168865
This project aims to understand why certain lung cells allow tuberculosis bacteria to grow easily, which could help us find new ways to fight the infection.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF ARKANSAS FOR MED SCIS (nih funded) |
| Locations | 1 site (LITTLE ROCK, UNITED STATES) |
| Trial ID | NIH-11168865 on ClinicalTrials.gov |
What this research studies
Our current approaches to tuberculosis often focus on the body's general immune response, but we know that different lung cells react differently to the infection. Specifically, lung alveolar macrophages, a type of immune cell, seem to let the bacteria grow quickly and spread early in the infection. We don't fully understand why these cells are so permissive, but we believe their origin and how they use energy (their metabolism) play a big role. By figuring out these underlying mechanisms, we hope to discover new targets for medicines or vaccines.
Who could benefit from this research
Good fit: Patients with tuberculosis or those at risk of infection could potentially benefit from future therapies developed from this foundational understanding.
Not a fit: Patients whose conditions are unrelated to tuberculosis or lung macrophage function would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new treatments or more effective vaccines for tuberculosis by targeting how lung cells respond to the infection.
How similar studies have performed: While the role of macrophage metabolism in TB is being explored, the specific focus on how the origin and metabolism of alveolar macrophages impact their permissiveness to Mtb is a novel area of investigation.
Where this research is happening
LITTLE ROCK, UNITED STATES
- UNIV OF ARKANSAS FOR MED SCIS — LITTLE ROCK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HUANG, LU — UNIV OF ARKANSAS FOR MED SCIS
- Study coordinator: HUANG, LU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.